The anomalous pharmacology of fentanyl

E Kelly, K Sutcliffe, D Cavallo… - British journal of …, 2023 - Wiley Online Library
Fentanyl is a key therapeutic, used in anaesthesia and pain management. It is also
increasingly used illicitly and is responsible for a large and growing number of opioid …

Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review

A Moustaqim-Barrette, D Dhillon, J Ng, K Sundvick… - BMC public health, 2021 - Springer
Background Opioid related overdoses and overdose deaths continue to constitute an urgent
public health crisis. The implementation of naloxone programs, such as 'take-home …

Steep increases in fentanyl-related mortality west of the Mississippi River: recent evidence from county and state surveillance

CL Shover, TO Falasinnu, CL Dwyer, NB Santos… - Drug and alcohol …, 2020 - Elsevier
Background Overdose deaths from synthetic opioids (eg, fentanyl) increased 10-fold in the
United States from 2013 to 2018, despite such opioids being rare in illicit drug markets west …

Shifting North American drug markets and challenges for the system of care

RM Krausz, JN Westenberg, N Mathew, G Budd… - International Journal of …, 2021 - Springer
Drug markets are dynamic systems which change based on demand, competition,
legislation and revenue. Shifts that are not met with immediate and appropriate responses …

Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders

R Abdelal, A Raja Banerjee, S Carlberg-Racich… - Harm Reduction …, 2022 - Springer
Background The increasing prevalence of highly potent, illicitly manufactured fentanyl and
its analogues (IMF) in the USA is exacerbating the opioid epidemic which has worsened …

Adverse events related to bystander naloxone administration in cases of suspected opioid overdose in British Columbia: an observational study

A Moustaqim-Barrette, K Papamihali, S Williams… - PLoS …, 2021 - journals.plos.org
Introduction Take-Home Naloxone programs have been introduced across North America in
response to rising opioid overdose deaths. There is currently limited real-world data on …

The need for multiple naloxone administrations for opioid overdose reversals: a review of the literature

R Abdelal, AR Banerjee, S Carlberg-Racich… - Substance …, 2022 - journals.sagepub.com
Background A growing challenge in the opioid epidemic is the rise of highly potent synthetic
opioids,(ie, illicitly manufactured fentanyl [IMF]) entering the US non-prescription opioid …

Clinical Pharmacokinetics and Pharmacodynamics of Naloxone

TI Saari, J Strang, O Dale - Clinical Pharmacokinetics, 2024 - Springer
Abstract Naloxone is a World Health Organization (WHO)-listed essential medicine and is
the first choice for treating the respiratory depression of opioids, also by lay-people …

Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from …

S Parkin, J Neale, C Brown, ANC Campbell… - International Journal of …, 2020 - Elsevier
Background Adverse reactions to naloxone, such as withdrawal symptoms and aggression,
are widely recognised in the literature by pharmaceutical manufacturers and clinical …

High-dose naloxone formulations are not as essential as we thought

PM Lemen, DP Garrett, E Thompson, M Aho… - Harm Reduction …, 2024 - Springer
Naloxone is an effective FDA-approved opioid antagonist for reversing opioid overdoses.
Naloxone is available to the public and can be administered through intramuscular (IM) …